Apr 25, 2017 | Clinical Trials, Information, Latest News
Shire studies SHP640 for infectious conjunctivitis The first U.S. patient has been enrolled in a phase 3 clinical trial for Shire’s SHP640, a combination broad-spectrum antiseptic and corticosteroid being evaluated for treating infectious keratitis in adults and...
Apr 24, 2017 | age-related macular degeneration (ARMD), Information, Latest News, macular degeneration, Our Blog
Women Face Higher Risk of Blindness Than Men American Academy of Ophthalmology urges women to make eye health a top priority by: American Academy of Ophthalmology SAN FRANCISCO, April 24, 2017 /PRNewswire-USNewswire/ — Studies show there is a gender gap in eye...
Apr 24, 2017 | Information, Latest News, Our Blog
Sight-restoring cornea cells grow in the lab for first time in transplant breakthrough The lab grown corneal cells could help prevent the need for corneal transplants In the US, 33,000 people per year undergo corneal transplant surgery The surgery replaces diseased...
Apr 20, 2017 | Information, Latest News, Our Blog
Sjogren’s, a disease you probably can’t see or pronounce, wreaks havoc on women by Stacey Burling, STAFF WRITER It took 10 years for Lisa Faricelli to get an explanation for the symptoms that were making her miserable. A former “superwoman” of a...
Apr 20, 2017 | Genetics, Information, Latest News, macular degeneration, Our Blog
Team characterizes the underlying cause of a form of macular degeneration by Katherine Unger Baillie The Penn-led research team characterized the underlying mechanism that leads to the blinding Best disease; a loss of the microvilli that support and...
Recent Comments